East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Rimegepant
Vydura
Routinely available
SMC (SMC2521)
09/08/2023

Indication

For the acute treatment of migraine with or without aura in adults. SMC restriction: for patients who have had inadequate symptom relief after trials of at least two triptans or in whom triptans are contraindicated or not tolerated; and have inadequate pain relief with non-steroidal anti-inflammato...

For the acute treatment of migraine with or without aura in adults. SMC restriction: for patients who have had inadequate symptom relief after trials of at least two triptans or in whom triptans are contraindicated or not tolerated; and have inadequate pain relief with non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol.

Therapeutic Area

Central nervous system

Status Description

Routinely available in line with national guidance

Formulation

Oral lyophilisate

Comments

August 2023 - Routinely available in line with national guidance.

Link to Advice

SMC2521

Advice Published

09/05/2023

SMC Submission Type

Full

SMC Status

Restricted